AN OPEN RANDOMIZED STUDY COMPARING DISULFIRAM AND ACAMPROSATE IN THE TREATMENT OF ALCOHOL DEPENDENCE
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
AIMS: To compare the efficacy of acamprosate (ACP) and disulfiram (DSF) for preventing alcoholic relapse in routine clinical practice. METHODS: One hundred alcoholic men with family members who would encourage medication compliance and accompany them for follow-up were randomly allocated to 8 months of treatment with DSF or ACP. Weekly group psychotherapy was also available. The psychiatrist, patient, and family member were aware of the treatment prescribed. Alcohol consumption, craving, and adverse events were recorded weekly for 3 months and then fortnightly. Serum gamma glutamyl transferase was measured at the start and the end of the study. RESULTS: At the end of the trial, 93 patients were still in contact. Relapse (the consumption of >5 drinks/40 g of alcohol) occurred at a mean of 123 days with DSF compared to 71 days with ACP (P = 0.0001). Eighty-eight per cent of patients on DSF remained abstinent compared to 46% with ACP (P = 0.0002). However, patients allocated to ACP had lower craving than those on DSF (P = 0.002). CONCLUSION: DSF is superior to ACP for preventing relapse in alcohol-dependent men with good family support. Further comparisons between these two drugs in different treatment settings and populations are warranted.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two studies with 171 participants comparing active pharmacologic interventions reported on alcohol consumption. These studies found evidence of a reduced likelihood of remission among participants who were allocated to receive acamprosate as compared to another active pharmacologic treatment (baclofen, disulfiram, or naltrexone; RR = 0.58, 95% CI 0.42 to 0.79; n = 2 trials, 171 participants; Heter”
From Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries (2023) · cites this paper as de Sousa 2005
In the citing paper
“This study found that relapse occurred significantly sooner among participants randomized to acamprosate as compared to disulfiram (de Sousa 2005).”
From Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries (2023) · cites this paper as de Sousa 2005
Citations
Cites
1 retracted
RETRACTED ARTICLE: Acamprosate and its efficacy in treating alcohol dependent adolescents
Niederhofer, H., & Staffen, W. (2003) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-003-0327-1 · Cited by 55 · cited 1×
“ACP reduces the severity of relapse in alcoholics undergoing abstinence-oriented treatment (Chick et al., 2003), and may even be effective in the management of alcohol-dependent adolescents ( Niederhofer and Staffen, 2003 ).”
BackgroundRetractedMcLELLAN, A. T., LUBORSKY, L., WOODY, G. E., & O??BRIEN, C. P. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,188
Anton, R. F., Moak, D. H., & Latham, P. (1995) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1995.tb01475.x · Cited by 677
The Severity of Alcohol Dependence Questionnaire: Its Use, Reliability and Validity
Stockwell, T., Murphy, D., & Hodgson, R. (1983) · British Journal of Addiction · doi:10.1111/j.1360-0443.1983.tb05502.x · Cited by 573 · cited 1×
“(ii) The Severity of Alcohol Dependence Scale (Stockwell et al., 1983).”
MethodMann, K., Lehert, P., & Morgan, M. Y. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000108656.81563.05 · Cited by 364
Combined Efficacy of Acamprosate and Disulfiram in the Treatment of Alcoholism: A Controlled Study
Besson, J., Aeby, F., Kasas, A., Lehert, P., & Potgieter, A. (1998) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb04295.x · Cited by 192
Does disulfiram have a role in alcoholism treatment today?
FULLER, R. K., & GORDIS, E. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00597.x · Cited by 182
Treating Alcohol and Drug Abuse: An Evidence Based Review
(2003) · Wiley eBooks · doi:10.1002/3527601465 · Cited by 117
A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence
DE SOUSA, A., & DE SOUSA, A. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh104 · Cited by 108
Verheul, R., Lehert, P., Geerlings, P. J., Koeter, M. W. J., & van den Brink, W. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1991-7 · Cited by 94
Cited by
Acamprosate for alcohol dependence
Rösner, S., Hackl-Herrwerth, A., Leucht, S., Lehert, P., Vecchi, S., & Soyka, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004332.pub2 · Cited by 412
Jørgensen, C. H., Pedersen, B., & Tønnesen, H. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01523.x · Cited by 366
Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis
Skinner, M. D., Lahmek, P., Pham, H., & Aubin, H.-J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087366 · Cited by 347
Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis
McPheeters, M., O’Connor, E. A., Riley, S., Kennedy, S. M., Voisin, C., Kuznacic, K., Coffey, C. P., Edlund, M. D., Bobashev, G., & Jonas, D. E. (2023) · JAMA · doi:10.1001/jama.2023.19761 · Cited by 285
Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
Substance use and addiction research in India
Murthy, P., Manjunatha, N., Subodh, B., Chand, P., & Benegal, V. (2010) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.69232 · Cited by 194
Dunlop, W. L., & Tracy, J. L. (2013) · Journal of Personality and Social Psychology · doi:10.1037/a0031185 · Cited by 166
Laaksonen, E., Koski-Jännes, A., Salaspuro, M., Ahtinen, H., & Alho, H. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agm136 · Cited by 147
“The De Sousas have compared DIS to NTX (De Sousa and De Sousa, 2004) and to ACA (de Sousa and de Sousa, 2005).”
MethodEvidence-Based Pharmacological Treatment of Substance Use Disorders and Pathological Gambling
van den Brink, W. (2012) · Current Drug Abuse Reviews · doi:10.2174/1874473711205010003 · Cited by 116
Medical Treatment of Alcohol Dependence: A Systematic Review
Miller, P. M., Book, S. W., & Stewart, S. H. (2011) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.42.3.b · Cited by 107
An open randomized trial comparing disulfiram and topiramate in the treatment of alcohol dependence
Sousa, A. A. D., Sousa, J. D., & Kapoor, H. (2007) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.05.012 · Cited by 96
Soyka, M., Kranzler, H. R., Hesselbrock, V., Kasper, S., Mutschler, J., Möller, H.-J., & The WFSBP Task Force on Treatment Guidelines for Substance Use Disorders (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1246752 · Cited by 85
Pharmacological approaches to reducing craving in patients with alcohol use disorders
Haass-Koffler, C. L., Leggio, L., & Kenna, G. A. (2014) · CNS Drugs · doi:10.1007/s40263-014-0149-3 · Cited by 83
Soyka, M., Kranzler, H. R., Berglund, M., Gorelick, D., Hesselbrock, V., Johnson, B. A., Möller, H.-J., THE WFSBP TASK FORCE ON TREATMENT G, Soyka, M., Kranzler, H. R., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970801896390 · Cited by 80
Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility
Witkiewitz, K. A., Saville, & Hamreus (2012) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s23184 · Cited by 78
Acamprosate: a review of its use in alcohol dependence
Plosker, G. L. (2015) · Drugs · doi:10.1007/s40265-015-0423-9 · Cited by 65
Malcolm, R., Olive, M. F., & Lechner, W. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740338.7.4.459 · Cited by 51
Diehl, A., Ulmer, L., Mutschler, J., Herre, H., Krumm, B., Croissant, B., Mann, K., & Kiefer, F. (2010) · Alcohol and Alcoholism · doi:10.1093/alcalc/agq017 · Cited by 49
Staton, C. A., Vissoci, J. R. N., El-Gabri, D., Adewumi, K., Concepcion, T., Elliott, S. A., Evans, D. R., Galson, S. W., Pate, C. T., Reynolds, L. M., et al. (2022) · PLOS Medicine · doi:10.1371/journal.pmed.1003961 · Cited by 41
“De Sousa and colleagues (2005) [47] India Biomedical treatments Private hospital adult psychiatric patients 100 High Abstinence days Days until relapse Drinks per drinking day Craving”
BackgroundRipley, T. L., & Stephens, D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01406.x · Cited by 50
Yoshimura, A., Kimura, M., Nakayama, H., Matsui, T., Okudaira, F., Akazawa, S., Ohkawara, M., Cho, T., Kono, Y., Hashimoto, K., et al. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12278 · Cited by 41
Entwicklungsprozess der DGPPN-Qualitätsindikatoren
Großimlinghaus, I., Falkai, P., Gäebel, W., Janssen, B., Reich‐Erkelenz, D., Wobrock, T., & Zielasek, J. (2013) · Der Nervenarzt · doi:10.1007/s00115-012-3705-4 · Cited by 43
Aguiar, P. M. V., Neto, D., Lambaz, R., Chick, J., & Ferrinho, P. D. L. G. M. (2012) · Alcohol and Alcoholism · doi:10.1093/alcalc/ags097 · Cited by 40
Schick, M. R., Spillane, N. S., & Hostetler, K. L. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14440 · Cited by 35
An Approach to the Patient with Substance Use and Abuse
Maldonado, J. R. (2010) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.08.010 · Cited by 35
Relationship between Craving and Early Relapse in Alcohol Dependence: A Short-Term Follow-up Study
Kharb, R., Shekhawat, L. S., Beniwal, R. P., Triptish Bhatia, A., & Deshpande, S. N. (2018) · Indian Journal of Psychological Medicine · doi:10.4103/ijpsym.ijpsym_558_17 · Cited by 31
“Indian literature has focused on craving chiefly to evaluate the efficacy of different medications,([23-30]) but craving has been less studied.”
BackgroundThe Pharmacotherapy of Alcohol Dependence: A State of the Art Review
Sousa, A. D. (2010) · Mens Sana monographs · doi:10.4103/0973-1229.58820 · Cited by 32
Alcohol abuse and related factors in Asia
Chen, C.-C., & Yin, S. (2008) · International Review of Psychiatry · doi:10.1080/09540260802344075 · Cited by 30
An open randomized trial comparing disulfiram and naltrexone in adolescents with alcohol dependence
De Sousa, A., & De Sousa, A. (2008) · Journal of Substance Use · doi:10.1080/14659890802305861 · Cited by 29
Badawy, A. A.-B., Bano, S., & Steptoe, A. (2011) · Alcohol and Alcoholism · doi:10.1093/alcalc/agr134 · Cited by 29
Tolerance to Disulfiram Induced by Chronic Alcohol Intake in the Rat
Tampier, L., Quintanilla, M. E., & Israel, Y. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00658.x · Cited by 28
Disulfiram in severe alcoholism–an open controlled study
Ulrichsen, J., Nielsen, M. K., & Ulrichsen, M. (2010) · Nordic Journal of Psychiatry · doi:10.3109/08039481003686180 · Cited by 26
Antonelli, M., Sestito, L., Tarli, C., & Addolorato, G. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.05.016 · Cited by 28
Thirthalli, J., & Chand, P. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32832a1dc0 · Cited by 26
Neto, D., Lambaz, R., & Tavares, J. (2007) · Alcohol and Alcoholism · doi:10.1093/alcalc/agm062 · Cited by 24
Disulfiram, an Option for the Treatment of Pathological Gambling?
Mutschler, J., Fauth‐Bühler, M., Grosshans, M., Diehl, A., Mann, K. F., & Kiefer, F. (2010) · Alcohol and Alcoholism · doi:10.1093/alcalc/agp093 · Cited by 24
Functional Social Support within a Medical Supervised Outpatient Treatment Program
Mutschler, J., Eifler, S., Dirican, G., Grosshans, M., Kiefer, F., Rössler, W., & Diehl, A. (2012) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2012.677889 · Cited by 23
Current and Future Drug Therapies for Alcohol Dependence
Rosenthal, R. N. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.000246223.94119.cd · Cited by 23
Supervised Disulfiram in the Treatment of Alcohol Use Disorder: A Commentary
Krampe, H., Spies, C., & Ehrenreich, H. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01519.x · Cited by 19
Mutschler, J., Grosshans, M., Koopmann, A., Hermann, D., Diehl, A., Mann, K. F., & Kiefer, F. (2010) · Alcohol and Alcoholism · doi:10.1093/alcalc/agq001 · Cited by 18
Effect of the threat of a disulfiram–ethanol reaction on cue reactivity in alcoholics
Skinner, M. D., Coudert, M., Berlin, I., Passeri, E., Michel, L., & Aubin, H.-J. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.06.011 · Cited by 17
Current progress in pharmacologic treatment strategies for alcohol dependence
Clapp, P. (2012) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.31 · Cited by 17
Teesson, M., Farrugia, P. L., Mills, K. L., Hall, W., & Baillie, A. (2012) · Substance Use & Misuse · doi:10.3109/10826084.2012.663283 · Cited by 19
Mutschler, J., Dirican, G., Funke, S., Obermann, C., Grosshans, M., Mann, K. F., Kiefer, F., & Diehl, A. (2011) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3182216fd5 · Cited by 17
Neto, D., Lambaz, R., Aguiar, P. M. V., & Chick, J. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn075 · Cited by 16
Sarkar, S., Tom, A., Das, S., Bharadwaj, B., & Ghosh, A. (2022) · Journal of Mental Health and Human Behaviour · doi:10.4103/jmhhb.jmhhb_191_20 · Cited by 15
Impact of brief relapse prevention intervention in patients with alcohol dependence in Zambia
Sheikh, W. A., Paul, R., Banda, H., Agath, K., & Luty, J. (2017) · Journal of Substance Use · doi:10.3109/14659891.2015.1090494 · Cited by 14
Status of disulfiram in present day alcoholic deaddiction therapy
Saldanha, E., & Palatty, P. L. (2011) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.75557 · Cited by 18
Disulfiram in the management of alcohol dependence: A comprehensive clinical review
Kalra, G., Sousa, A. D., & Shrivastava, A. (2014) · Open Journal of Psychiatry · doi:10.4236/ojpsych.2014.41007 · Cited by 39
Sustained-Release Naltrexone Formulations for the Treatment of Alcohol and Opioid Dependence
Volpicelli, J. R., & Fenton, M. C. (2006) · Future Neurology · doi:10.2217/14796708.1.4.389 · Cited by 14
“However, when disulfiram use is supervised, it can be effective in reducing excessive drinking in alcohol-dependent patients [6,7].”
BackgroundTarli, C., Mirijello, A., & Addolorato, G. (2022) · Seminars in Liver Disease · doi:10.1055/a-1798-2872 · Cited by 12
A breath test to assess compliance with disulfiram
Fletcher, K., Stone, E., Mohamad, M. W., Faulder, C. G., Faulder, R. M., Jones, K., Morgan, D., Wegerdt, J., Kelly, M., & Chick, J. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01602.x · Cited by 12
Greene, M. C., Kane, J., Alto, M., Giusto, A., Lovero, K., Stockton, M., McClendon, J., Nicholson, T., Wainberg, M. L., Johnson, R. M., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013350.pub2 · Cited by 11
Bogenschutz, M. P., Bhatt, S. R., Bohan, J., Foster, B., Romo, P., Wilcox, C. E., & Tonigan, J. S. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2016.1168430 · Cited by 11
Kiefer, F., & Mann, K. F. (2013) · Springer eBooks · doi:10.1007/978-3-642-27772-6_166-2 · Cited by 11
Bharadwaj, B., Selvakumar, N., & Kuppili, P. P. (2018) · Industrial Psychiatry Journal · doi:10.4103/ipj.ipj_79_17 · Cited by 10
Acamprosate: a new tool in the battle against alcohol dependence
Wright, T. M., & Myrick, H. (2006) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.2006.2.4.445 · Cited by 11
Díaz-Morán, S., & Fernández‐Teruel, A. (2012) · Anales de Psicología · doi:10.6018/analesps.29.1.135131 · Cited by 12
The Relative Safety of Disulfiram
Alharbi, F., & el‐Guebaly, N. (2012) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0b013e3182625beb · Cited by 8
A comparative study using Disulfiram and Naltrexone in alcohol-dependent adolescents
Sousa, A. D. (2013) · Journal of Substance Use · doi:10.3109/14659891.2013.813084 · Cited by 8
Pharmakologische Rückfallprophylaxe bei Alkoholabhängigkeit
Kiefer, F., & Löber, S. (2007) · Psychiatrie und Psychotherapie up2date · doi:10.1055/s-2007-986228 · Cited by 7
Disulfiram in Context: Structure and Safety
Martin, B., & Beresford, T. P. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000280312.58495.35 · Cited by 7
Treatment outcome and its predictors among A sian problem drinkers
Manning, V., Gomez, B. M., Koh, P. K., Ng, A. Y., Guo, S. L., Kandasami, G., & Wong, K. E. (2012) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2012.00518.x · Cited by 7
Basu, D., & Joseph, J. (2019) · Journal of Postgraduate Medicine Education and Research · doi:10.5005/jp-journals-10028-1307 · Cited by 6
Basu, D., Ghosh, A., Patra, B., & Subodh, B. N. (2015) · Springer eBooks · doi:10.1007/978-81-322-1674-2_19 · Cited by 5
Disulfiram (Antabus ®) in der Suchtbehandlung
Olbrich, R., & Olbrich, R. (2007) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/2007.02.02 · Cited by 5
Manca, F., Zhang, L., Fitzgerald, N., Ho, F. K. W., Innes, H. A., Jani, B., Katikireddi, S. V., McAuley, A., Sharp, C., & Lewsey, J. (2024) · Drug and Alcohol Review · doi:10.1111/dar.13841 · Cited by 4
Zyl, P. M. V. (2016) · African Journal of Primary Health Care & Family Medicine · doi:10.4102/phcfm.v8i1.1053 · Cited by 3
Cho, T., Negoro, H., Saka, Y., Morikawa, M., & Kishimoto, T. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s111230 · Cited by 5
Brewer, C. L., & Streel, E. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-197-0_26 · Cited by 4
The evidence for drug treatment of alcohol dependence in liver transplant patients
Beresford, T. P., & Martin, B. (2007) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32803fb77d · Cited by 3
Pharmacotherapeutic Treatment of Alcohol Dependence: An Overview
Graves, E., & Goodwin, L. R. (2008) · Journal of Teaching in the Addictions · doi:10.1080/15332700802072290 · Cited by 3
“For example, De Sousa and De Sousa's (2005) study of the differential effects of acamprosate and disulfiram on relapse among men with adequate family support found that disulfiram was more effective in preventing relapse than acamprosate.”
BackgroundDrug and alcohol addiction: new pharmacotherapies
Luty, J. S. (2015) · BJPsych Advances · doi:10.1192/apt.bp.114.013367 · Cited by 4
Disulfiram: The Survivor Medication
Alharbi, F., & el‐Guebaly, N. (2012) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0b013e318246f4af · Cited by 2
Basu, D., Ghosh, A., & Sarkar, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800212-4.00094-7 · Cited by 3
Sharma, A. D., Rikhari, P., Shukla, A. K., & Rikhari, P. (2024) · Cureus · doi:10.7759/cureus.58174 · Cited by 2
“…and disulfiram found acamprosate to be superior in terms of the number of patients completing the study, number of patients remaining abstinent, number of patients who relapse, mean days to first alcohol consumption, mean days to first relapse, and number of drinks consumed at one time [18].”
BackgroundAre Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?
Kleczkowska, P., Smaga, I., Filip, M., & Bujalska‐Zadrożny, M. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9655-z · Cited by 2
Investigating a Model for Fetal Alcohol Damage in Caenorhabditis elegans
Kondo, L. M. (2012) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/ccbt-0g71 · Cited by 1
“Studies have shown that Disulfiram increases both abstinence and the number of days until relapse (Jørgensen et al., 2011; De Sousa and De Sousa, 2004, 2005, 2008; De Sousa et al., 2008; Laaksonen et al., 2008).”
BackgroundBrewer, C. L. (2010) · Intervention · doi:10.1097/wtf.0b013e328341363b · Cited by 1
Treatment of alcohol dependence
Chick, J. (2012) · doi:10.1093/med/9780199696758.003.0059 · Cited by 1
Joseph, J., & KHAKHA, D. C. (2024) · Addiction and Health · doi:10.34172/ahj.1537 · Cited by 1
Unhealthy Alcohol and Drug Use in Primary Care
Bierer, M. F., & Saitz, R. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_42 · Cited by 1
Reply to Comments by Mr Martin and Dr Beresford
Suh, J. J., Gallis, T. L., Kampman, K. M., & Pettinati, H. M. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000280313.96613.72 · Cited by 1
Circuit breakers for addiction
Foy, A. (2007) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2007.01350.x · Cited by 1
Basil, B., Thomas, M., Chakrabarti, I., George, V., Mathews, M., & Adetunji, B. (2005) · PubMed
Aslan, A. A., Yalçın, Ö., Arıkan, Z., Kuruoğlu, A., Çoşar, B., & Konuk, N. (2013) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20120903122839
“Recent open-label studies have showed that disulfiram was superior to acamprosate, naltrexone, and topiramate (12-15).”
Berglund, M. (2007) · Lund University Publications (Lund University)
13 Common Errors in Psychopharmacology
Ameen, S. (2015) · Kerala Journal of Psychiatry · doi:10.30834/kjp.28.2.2015.54 · Cited by 2
Pharmacological treatment options for alcohol use disorder
Evren, C., & Bozkurt, M. (2015) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn20152804001
Specialist treatment of drinking problems
Humphreys, K. N., & Lingford-Hughes, A. R. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316258057.014
Interdictores en el tratamiento del alcoholismo. Una revisión crítica
García, S. S. G. (2014) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia)
Alcohol problems in the general hospital
Chick, J. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543975.009
Disulfiram in Comparison and Combination with Other Agents in the Management of Alcohol Dependence
Sousa, A. D. (2019) · Springer eBooks · doi:10.1007/978-981-32-9876-7_5
Cho, T. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_342-1
Treatment: Context and content
Humphreys, K. N., & Lingford-Hughes, A. R. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316258057.009
Kiefer, F., & Mann, K. (2010) · Springer eBooks · doi:10.1007/978-3-540-68706-1_166
Kiefer, F., & Mann, K. F. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_166
Cho, T. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_342-2
Cho, T. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_342
Pharmacological actions of commonly used drugs
Yates, J. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90578-7.00008-6
Metadata
- Authors
- DE SOUSA, A., & DE SOUSA, A.
- Venue
- Alcohol and Alcoholism
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-05
- Volume
- 40
- Issue
- 6
- Pages
- 545-548
- ISSN
- 0735-0414 (ISSN-L)
- 1464-3502
- OpenAlex
- W2103224516
- Semantic Scholar
- 8b02957b64ef07fde9156144bc3786e4fa1dd551
- Cited by
- 107
- References
- 22
- Citations by year
- 2026: 2 · 2024: 4 · 2023: 2 · 2022: 5 · 2020: 3 · 2019: 2 · 2018: 2 · 2016: 10 · 2015: 6 · 2014: 5 · 2013: 6 · 2012: 14
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Alcohol and Alcoholism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
- Keywords
- disulfiram, acamprosate, alcoholism, alcohol relapse prevention, alcohol craving, alcohol abstinence, family support, medication adherence, group therapy, gamma-glutamyl transferase
- MeSH terms
- Acamprosate, Adult, Alanine Transaminase, Alcohol Deterrents, Ethanol, Alcoholism, Aspartate Aminotransferases, Disulfiram, Female, Follow-Up Studies, gamma-Glutamyltransferase, Hospitals, Psychiatric, Humans, India, Male, Middle Aged, Substance Withdrawal Syndrome, Taurine, Temperance, Hospitals, Private, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.